☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Simcere
Simcere Enters into an Exclusive License Agreement with Connect Biopharm for Rademikibart
November 24, 2023
Simcere Entered into an Exclusive License Agreement with Idorsia for Daridorexant in China
November 16, 2022
Simcere Entered into an Exclusive License Agreement with Almirall for SIM0278 to Treat Autoimmune Diseases
September 29, 2022
PharmaShots Weekly Snapshot (September 23-27, 2019)
September 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
